SUBSEQUENT EVENTS	12 Months Ended
Feb. 29, 2012
Notes to Financial Statements
NOTE 8 - SUBSEQUENT EVENTS	Yale University Payment The Company has agreed to pay $112,000 to the Yale University Medical School Department of Pathology in return for certain work to validate the Company’s technology in the fields of breast cancer and lung cancer. The payment is being made in two tranches of $56,000.00 each, the first of which has been paid in the fourth calendar quarter of 2011 and the second of which has been paid in the first calendar quarter of 2012, subsequent to February 29, 2012 May 2012 Private Placement On May 1, 2012, we entered into a securities purchase agreement with certain institutional and accredited investors for the issuance and sale in a private placement consisting of, in the aggregate, (a) 880,000 shares of common stock, par value $0.0001 per share, at a price per share of $1.00 and (b) four-year warrants to purchase up to 220,000 shares of common stock at an exercise price of $1.40 per share, for aggregate gross proceeds of $880,000 (the “May 2012 Private Placement”). As of June 13, 2012, we have closed on $855,000 and have a subscription receivable for the remaining amount. In connection with the May 2012 Private Placement, we also entered into a registration rights agreement with the investors whereby we agreed to file a registration statement with the Securities and Exchange Commission to register for resale the shares of common stock and the shares of common stock underlying the warrants within 120 calendar days of the closing date, and to have the registration statement declared effective within 180 calendar days of the closing date or within 270 calendar days of the closing date in the event of a full review of the registration statement by the Securities and Exchange Commission. Restricted Stock Grant On May 22, 2012, the Company issued 50,000 restricted shares each to two of our directors, Patrick T. Mooney and Johan M. “Thijs” Spoor, for services rendered to the Company.

SUBSEQUENT EVENTS

12 Months Ended

Feb. 29, 2012

Yale University Payment

The Company has agreed to pay $112,000 to the Yale University Medical School Department of Pathology in return for certain work to validate the Company’s technology in the fields of breast cancer and lung cancer. The payment is being made in two tranches of $56,000.00 each, the first of which has been paid in the fourth calendar quarter of 2011 and the second of which has been paid in the first calendar quarter of 2012, subsequent to February 29, 2012

May 2012 Private Placement

On May 1, 2012, we entered into a securities purchase agreement with certain institutional and accredited investors for the issuance and sale in a private placement consisting of, in the aggregate, (a) 880,000 shares of common stock, par value $0.0001 per share, at a price per share of $1.00 and (b) four-year warrants to purchase up to 220,000 shares of common stock at an exercise price of $1.40 per share, for aggregate gross proceeds of $880,000 (the “May 2012 Private Placement”). As of June 13, 2012, we have closed on $855,000 and have a subscription receivable for the remaining amount.

In connection with the May 2012 Private Placement, we also entered into a registration rights agreement with the investors whereby we agreed to file a registration statement with the Securities and Exchange Commission to register for resale the shares of common stock and the shares of common stock underlying the warrants within 120 calendar days of the closing date, and to have the registration statement declared effective within 180 calendar days of the closing date or within 270 calendar days of the closing date in the event of a full review of the registration statement by the Securities and Exchange Commission.

Restricted Stock Grant

On May 22, 2012, the Company issued 50,000 restricted shares each to two of our directors, Patrick T. Mooney and Johan M. “Thijs” Spoor, for services rendered to the Company.